Insmed stock forecast
Insmed (IM8N) Stock Forecast & Price Target
IM8N Analyst Ratings
IM8N Stock 12 Month Forecast
Average Price Target
€174.67▲(32.13% Upside)Detailed List of Analyst Forecasts​
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Jason Zemansky | Bank of America Securities | €186.96 | buy | 41.42%Upside | Reiterated | 11/20/26 | ||
| Graig Suvannavejh | Mizuho Securities | €144.09 | buy | 9.00%Upside | Reiterated | 11/19/26 | ||
| Tiago Fauth | Raymond James | ― | buy | ― | Reiterated | 11/19/26 | ||
| Vamil Divan | Guggenheim | €183.31 | buy | 38.66%Upside | Reiterated | 11/19/26 | ||
| Leonid Timashev | RBC Capital | €177.84 | buy | 34.52%Upside | Reiterated | 11/17/26 | ||
| Maxwell Skor | Morgan Stanley | €194.25 | buy | 46.94%Upside | Reiterated | 11/13/26 | ||
| Gavin Clark-Gartner | Evercore ISI | €155.04 | buy | 17.27%Upside | Reiterated | 11/05/26 | ||
| Matthew Caufield | H.C. Wainwright | €200.64 | buy | 51.77%Upside | Initiated | 11/04/26 | ||
| Conor MacKay | BMO Capital | €175.10 | buy | 32.45%Upside | Reiterated | 11/02/26 | ||
| Eliana Merle | Barclays | €188.78 | buy | 42.80%Upside | Reiterated | 11/02/26 | ||
| Leerink Partners | €191.52→€180.57 | buy | 36.59%Upside | Reiterated | 11/02/26 | |||
| Ashwani Verma | UBS | €156.86 | buy | 18.65%Upside | Reiterated | 10/30/26 | ||
| Andrea Newkirk | Goldman Sachs | €171.45→€176.92 | buy | 33.83%Upside | Reiterated | 10/30/26 | ||
| Adam Walsh | Roth MKM | €180.57→€186.04 | buy | 40.73%Upside | Reiterated | 10/29/26 | ||
| Benjamin Burnett | Wells Fargo | €154.12 | buy | 16.58%Upside | Assigned | 10/13/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Jason ZemanskyBank of America Securities | BuyReiterated€186.96 | 11/20/26 | 41.42%Upside | ||
| Graig SuvannavejhMizuho Securities | BuyReiterated€144.09 | 11/19/26 | 9.00%Upside | ||
| Tiago FauthRaymond James | BuyReiterated | 11/19/26 | ― | ||
| Vamil DivanGuggenheim | BuyReiterated€183.31 | 11/19/26 | 38.66%Upside | ||
| Leonid TimashevRBC Capital | BuyReiterated€177.84 | 11/17/26 | 34.52%Upside | ||
| Maxwell SkorMorgan Stanley | BuyReiterated€194.25 | 11/13/26 | 46.94%Upside | ||
| Gavin Clark-GartnerEvercore ISI | BuyReiterated€155.04 | 11/05/26 | 17.27%Upside | ||
| Matthew CaufieldH.C. Wainwright | BuyInitiated€200.64 | 11/04/26 | 51.77%Upside | ||
| Conor MacKayBMO Capital | BuyReiterated€175.10 | 11/02/26 | 32.45%Upside | ||
| Eliana MerleBarclays | BuyReiterated€188.78 | 11/02/26 | 42.80%Upside | ||
| BuyReiterated€191.52→€180.57 | 11/02/26 | 36.59%Upside | |||
| Ashwani VermaUBS | BuyReiterated€156.86 | 10/30/26 | 18.65%Upside | ||
| Andrea NewkirkGoldman Sachs | BuyReiterated€171.45→€176.92 | 10/30/26 | 33.83%Upside | ||
| Adam WalshRoth MKM | BuyReiterated€180.57→€186.04 | 10/29/26 | 40.73%Upside | ||
| Benjamin BurnettWells Fargo | BuyAssigned€154.12 | 10/13/26 | 16.58%Upside |
Best Analysts Covering Insmed
Copying Jessica Fye's trades and holding each position for 3 Months would result in 72.73% of your transactions generating a profit, with an average return of +22.36% per trade.
Copying Tiago Fauth's trades and holding each position for 1 Year would result in 84.21% of your transactions generating a profit, with an average return of +80.11% per trade.
Copying Jessica Fye's trades and holding each position for 2 Years would result in 95.45% of your transactions generating a profit, with an average return of +103.66% per trade.
IM8N Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 51 | 46 | 42 | 40 | 36 |
| Buy | 8 | 14 | 15 | 12 | 6 |
| Hold | 0 | 0 | 0 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 59 | 60 | 57 | 53 | 43 |
In the current month, IM8N has received 42 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. IM8N average Analyst price target in the past 3 months is 174.67.
IM8N Financial Forecast
IM8N Earnings Forecast
Next quarter’s earnings estimate for IM8N is -EUR 0.28 with a range of -EUR 0.81 to EUR 0.15. The previous quarter’s EPS was -EUR 0.42. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
IM8N Sales Forecast
Next quarter’s sales forecast for IM8N is EUR 549.16M with a range of EUR 513.90M to EUR 589.08M. The previous quarter’s sales results were EUR 476.99M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

